Stay updated on Nivolumab for Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Hematologic Malignancies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.3 to v3.5.4, indicating a minor version bump of the page. This reflects an administrative update rather than a substantive change to the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-15T04:14:03.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, indicating a small update to the record's metadata rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-04-30T17:48:47.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision v3.5.2 added and revision v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:23.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T16:52:20.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor backend/UI release with no visible changes to study data or navigation.
    Difference
    0.1%
    Check dated 2026-03-11T14:39:04.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added site revision note 'Revision: v3.4.2' and removed a funding-status notice; these are minor metadata changes that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T09:24:40.000Z thumbnail image

Stay in the know with updates to Nivolumab for Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Hematologic Malignancies Clinical Trial page.